Claranova SE carries a market capitalization of 1.58M, placing it among publicly traded companies globally. Its enterprise value stands at -7.60M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.58M |
| Enterprise Value | -7.60M |
Claranova SE currently has 2.31M shares outstanding.
| Shares Outstanding | 2.31M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Claranova SE maintains a current ratio of 1.28, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.28 |
| Quick Ratio | 0.21 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Claranova SE's stock has declined approximately -45.16129% over the past 52 weeks. The 50-day moving average sits at 0.77, while the 200-day moving average is 1.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -45.16129% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.11 |
| Average Volume (20 Days) | N/A |
Total book value stands at 8.01M, with working capital of 12.40M providing operational flexibility.
| Cash & Cash Equivalents | 9.45M |
| Total Debt | N/A |
| Net Debt | -9.45M |
| Equity (Book Value) | 8.01M |
| Book Value Per Share | N/A |
| Working Capital | 12.40M |
Claranova SE posts an Altman Z-Score of 0.31, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.31 |